International Journal of Cancer Management

Published by: Kowsar

The Role of Interleukin-8 and Its Mechanism in Patients with Breast Cancer: Its Relation with Oxidative Stress and Estrogen Receptor

Robab Sheikhpour 1 , *
Author Information
1 Hematology and Oncology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Article information
  • International Journal of Cancer Management: September 2017, 10 (9); e8791
  • Published Online: September 30, 2017
  • Article Type: Review Article
  • Received: September 6, 2016
  • Revised: October 22, 2016
  • Accepted: September 12, 2017
  • DOI: 10.5812/ijcm.8791

To Cite: Sheikhpour R. The Role of Interleukin-8 and Its Mechanism in Patients with Breast Cancer: Its Relation with Oxidative Stress and Estrogen Receptor, Int J Cancer Manag. 2017 ; 10(9):e8791. doi: 10.5812/ijcm.8791.

Copyright © 2017, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
  • 1. Sheikhpour R, Ghassemi N, Yaghmaei P, Mohiti Ardekani J, Shiryazd M. Immunohistochemical assessment of p53 protein and its correlation with clinicopathological characteristics in breast cancer patients. Indian J Sci Technol. 2014;7(4):472-9.
  • 2. Sheikhpour R, Agha Sarrama R, Sheikhpour R . Particle swarm optimization for bandwidth determination andfeature selection of kernel density estimation based classifiers indiagnosis of breast cancer. Appl Soft Comput. 2016;40:113-31.
  • 3. Hamed EA, Zakhary MM, Maximous DW. Apoptosis, angiogenesis, inflammation, and oxidative stress: basic interactions in patients with early and metastatic breast cancer. J Cancer Res Clin Oncol. 2012;138(6):999-1009. doi: 10.1007/s00432-012-1176-4. [PubMed: 22362301].
  • 4. Zuccari DA, Leonel C, Castro R, Gelaleti GB, Jardim BV, Moscheta MG. An immunohistochemical study of interleukin-8 (IL-8) in breast cancer. Acta Histochem. 2012;114(6):571-6. doi: 10.1016/j.acthis.2011.10.007. [PubMed: 22244449].
  • 5. Todorovic-Rakovic N, Milovanovic J. Interleukin-8 in breast cancer progression. J Interferon Cytokine Res. 2013;33(10):563-70. doi: 10.1089/jir.2013.0023. [PubMed: 23697558].
  • 6. Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell. 2004;6(5):447-58. doi: 10.1016/j.ccr.2004.09.028. [PubMed: 15542429].
  • 7. de Andres PJ, Illera JC, Caceres S, Diez L, Perez-Alenza MD, Pena L. Increased levels of interleukins 8 and 10 as findings of canine inflammatory mammary cancer. Vet Immunol Immunopathol. 2013;152(3-4):245-51. doi: 10.1016/j.vetimm.2012.12.010. [PubMed: 23351639].
  • 8. Cacev T, Radosevic S, Krizanac S, Kapitanovic S. Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis. 2008;29(8):1572-80. doi: 10.1093/carcin/bgn164. [PubMed: 18628251].
  • 9. Milovanovic J, Todorovic-Rakovic N, Abu Rabi Z. The prognostic role of interleukin-8 (IL-8) and matrix metalloproteinases -2 and -9 in lymph node-negative untreated breast cancer patients. J Balkan Union Oncol. 2013;18(4):866-73.
  • 10. Lin Y, Huang R, Chen L, Li S, Shi Q, Jordan C. Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int J Cancer. 2004;109(4):507-15. doi: 10.1002/ijc.11724. [PubMed: 14991571].
  • 11. Chen Y, Chen L, Li JY, Mukaida N, Wang Q, Yang C. ERbeta and PEA3 co-activate IL-8 expression and promote the invasion of breast cancer cells. Cancer Biol Ther. 2011;11(5):497-511.
  • 12. Zarogoulidis P, Katsikogianni F, Tsiouda T, Sakkas A, Katsikogiannis N, Zarogoulidis K. Interleukin-8 and interleukin-17 for cancer. Cancer Invest. 2014;32(5):197-205. doi: 10.3109/07357907.2014.898156. [PubMed: 24669909].
  • 13. Kassim SK, El-Salahy EM, Fayed ST, Helal SA, Helal T, Azzam Eel D. Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients. Clin Biochem. 2004;37(5):363-9. doi: 10.1016/j.clinbiochem.2004.01.014. [PubMed: 15087251].
  • 14. Mayerhofer K, Bodner K, Bodner-Adler B, Schindl M, Kaider A, Hefler L. Interleukin-8 serum level shift in patients with ovarian carcinoma undergoing paclitaxel-containing chemotherapy. Cancer. 2001;91(2):388-93.
  • 15. Kamalakar A, Bendre MS, Washam CL, Fowler TW, Carver A, Dilley JD. Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans. Bone. 2014;61:176-85. doi: 10.1016/j.bone.2014.01.015. [PubMed: 24486955].
  • 16. Cheng D, Hao Y, Zhou W, Ma Y. Positive association between Interleukin-8 -251A > T polymorphism and susceptibility to gastric carcinogenesis: a meta-analysis. Cancer Cell Int. 2013;13(1):100. doi: 10.1186/1475-2867-13-100. [PubMed: 24143859].
  • 17. Kitadai Y, Takahashi Y, Haruma K, Naka K, Sumii K, Yokozaki H. Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br J Cancer. 1999;81(4):647-53. doi: 10.1038/sj.bjc.6690742. [PubMed: 10574250].
  • 18. Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev. 2001;12(4):375-91. [PubMed: 11544106].
  • 19. Heidemann J, Ogawa H, Dwinell MB, Rafiee P, Maaser C, Gockel HR. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J Biol Chem. 2003;278(10):8508-15. doi: 10.1074/jbc.M208231200. [PubMed: 12496258].
  • 20. Brat DJ, Bellail AC, Van Meir EG. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol. 2005;7(2):122-33. doi: 10.1215/S1152851704001061. [PubMed: 15831231].
  • 21. Kuai WX, Wang Q, Yang XZ, Zhao Y, Yu R, Tang XJ. Interleukin-8 associates with adhesion, migration, invasion and chemosensitivity of human gastric cancer cells. World J Gastroenterol. 2012;18(9):979-85. doi: 10.3748/wjg.v18.i9.979. [PubMed: 22408359].
  • 22. Bao BY, Yao J, Lee YF. 1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis. Carcinogenesis. 2006;27(9):1883-93. doi: 10.1093/carcin/bgl041. [PubMed: 16624828].
  • 23. Freund A, Chauveau C, Brouillet JP, Lucas A, Lacroix M, Licznar A. IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells. Oncogene. 2003;22(2):256-65. doi: 10.1038/sj.onc.1206113. [PubMed: 12527894].
  • 24. Jundi K, Greene CM. Transcription of Interleukin-8: How Altered Regulation Can Affect Cystic Fibrosis Lung Disease. Biomolecules. 2015;5(3):1386-98. doi: 10.3390/biom5031386. [PubMed: 26140537].
  • 25. Shao N, Lu Z, Zhang Y, Wang M, Li W, Hu Z. Interleukin-8 upregulates integrin beta3 expression and promotes estrogen receptor-negative breast cancer cell invasion by activating the PI3K/Akt/NF-kappaB pathway. Cancer Lett. 2015;364(2):165-72. doi: 10.1016/j.canlet.2015.05.009. [PubMed: 25979232].
  • 26. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. Multiple control of interleukin-8 gene expression. J Leukoc Biol. 2002;72(5):847-55. [PubMed: 12429706].
  • 27. De Oliveira LG, Lash GE, Murray-Dunning C, Bulmer JN, Innes BA, Searle RF. Role of interleukin 8 in uterine natural killer cell regulation of extravillous trophoblast cell invasion. Placenta. 2010;31(7):595-601.
  • 28. Tefferi A, Vaidya R, Caramazza D, Finke C, Lasho T, Pardanani A. Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study. J Clin Oncol. 2011;29(10):1356-63. doi: 10.1200/JCO.2010.32.9490. [PubMed: 21300928].
  • 29. Asaei S, Rasouli M, Moravej A. Interleukin-8 but not interleukin-6 variant may affect susceptibility to brucellosis. Iran J Immunol. 2013;10(3):158-66. [PubMed: 24076593].
  • 30. Wu K, Katiyar S, Li A, Liu M, Ju X, Popov VM. Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8. Proc Natl Acad Sci U S A. 2008;105(19):6924-9. doi: 10.1073/pnas.0802085105. [PubMed: 18467491].
  • 31. Pang X, Li K, Wei L, Huang Y, Su M, Wang L. [IL-8 inhibits the apoptosis of MCF-7 human breast cancer cells by up-regulating Bcl-2 and down-regulating caspase-3]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015;31(3):307-11. [PubMed: 25744832].
  • 32. Mohamed MM, El-Ghonaimy EA, Nouh MA, Schneider RJ, Sloane BF, El-Shinawi M. Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties. Int J Biochem Cell Biol. 2014;46:138-47. doi: 10.1016/j.biocel.2013.11.015. [PubMed: 24291763].
  • 33. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res. 2008;14(21):6735-41. doi: 10.1158/1078-0432.CCR-07-4843. [PubMed: 18980965].
  • 34. Malonia SK, Yadav B, Sinha S, Lazennec G, Chattopadhyay S. Chromatin remodeling protein SMAR1 regulates NF-kappaB dependent Interleukin-8 transcription in breast cancer. Int J Biochem Cell Biol. 2014;55:220-6. doi: 10.1016/j.biocel.2014.09.008. [PubMed: 25239884].
  • 35. Reed MJ, Christodoulides A, Koistinen R, Seppala M, Teale JD, Ghilchik MW. The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer. Int J Cancer. 1992;52(2):208-12. [PubMed: 1381703].
  • 36. Green AR, Green VL, White MC, Speirs V. Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumours. Int J Cancer. 1997;72(6):937-41. [PubMed: 9378554].
  • 37. Bendre MS, Gaddy-Kurten D, Mon-Foote T, Akel NS, Skinner RA, Nicholas RW. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Cancer Res. 2002;62(19):5571-9. [PubMed: 12359770].
  • 38. Benoy IH, Salgado R, Van Dam P, Geboers K, Van Marck E, Scharpe S. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin Cancer Res. 2004;10(21):7157-62. doi: 10.1158/1078-0432.CCR-04-0812. [PubMed: 15534087].
  • 39. Freund A, Jolivel V, Durand S, Kersual N, Chalbos D, Chavey C. Mechanisms underlying differential expression of interleukin-8 in breast cancer cells. Oncogene. 2004;23(36):6105-14. doi: 10.1038/sj.onc.1207815. [PubMed: 15208657].
  • 40. Simeone AM, Nieves-Alicea R, McMurtry VC, Colella S, Krahe R, Tari AM. Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells. Int J Oncol. 2007;30(4):785-92. [PubMed: 17332916].
  • 41. Derin D, Soydinc HO, Guney N, Tas F, Camlica H, Duranyildiz D. Serum IL-8 and IL-12 levels in breast cancer. Med Oncol. 2007;24(2):163-8. [PubMed: 17848739].
  • 42. Lyon DE, McCain NL, Walter J, Schubert C. Cytokine comparisons between women with breast cancer and women with a negative breast biopsy. Nurs Res. 2008;57(1):51-8. doi: 10.1097/01.NNR.0000280655.58266.6c. [PubMed: 18091292].
  • 43. Singh JK, Simoes BM, Howell SJ, Farnie G, Clarke RB. Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells. Breast Cancer Res. 2013;15(4):210. doi: 10.1186/bcr3436. [PubMed: 24041156].
  • 44. Kim S, Lee J, Jeon M, Lee JE, Nam SJ. MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells. Tumour Biol. 2016;37(4):4991-9. doi: 10.1007/s13277-015-4345-7. [PubMed: 26537583].
  • 45. Chavey C, Muhlbauer M, Bossard C, Freund A, Durand S, Jorgensen C. Interleukin-8 expression is regulated by histone deacetylases through the nuclear factor-kappaB pathway in breast cancer. Mol Pharmacol. 2008;74(5):1359-66. doi: 10.1124/mol.108.047332. [PubMed: 18669446].
  • 46. Yao C, Lin Y, Chua MS, Ye CS, Bi J, Li W. Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells. Int J Cancer. 2007;121(9):1949-57. doi: 10.1002/ijc.22930. [PubMed: 17621625].
  • 47. Singh RP, Sharad S, Kapur S. Free radicals and oxidative stress in neurodegenerative diseases: Relevance of dietary antioxidants. J Indian Acad Clinic Med. 2004;5(3):218-25.
  • 48. Sheikhpour R. Diabetes and Oxidative Stress: The Mechanism and Action. Iran J Diab Obes. 2013;5(1):40-6.
  • 49. Kangralkar VA, Patil SD, Bandivadekar RM. Oxidative stress and diabetes: A review. Int J Pharm Appl. 2010;1(1):38-45.
  • 50. Sheikhpour R, Yaghmaei P. A survey on herbal medicines for hypoglycemia in diabetic patients. Iran J Diab Obes. 2012;4(1):40-50.
  • 51. Vincent AM, Russell JW, Low P, Feldman EL. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev. 2004;25(4):612-28. doi: 10.1210/er.2003-0019. [PubMed: 15294884].
  • 52. Thyagarajan A, Jiang J, Hopf A, Adamec J, Sliva D. Inhibition of oxidative stress-induced invasiveness of cancer cells by Ganoderma lucidum is mediated through the suppression of interleukin-8 secretion. Int J Mol Med. 2006;18(4):657-64. [PubMed: 16964420].
  • 53. O'Hara A. M , Bhattacharyya A, Mifflin RC, Smith MF, Ryan K. A , Scott K. G.-E . Interleukin-8 Induction by Helicobacter pylori in Gastric Epithelial Cells is Dependent on Apurinic/Apyrimidinic Endonuclease-1/Redox Factor-1. J Immunol. 2006;177:7990-9.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments